De novo small supernumerary marker chromosomes detected on 143 000 consecutive prenatal diagnoses: chromosomal distribution, frequencies, and characterization combining molecular cytogenetics approaches
ABSTRACT Objective The risk of clinical consequences in prenatal cases with de novo small supernumerary marker chromosomes (sSMC), often in mosaic conditions, is not easy to predict, which results in difficulties in genetic counseling. Method In this study, we evaluated the frequency, the chromosoma...
Saved in:
Published in | Prenatal diagnosis Vol. 34; no. 5; pp. 460 - 468 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Blackwell Publishing Ltd
01.05.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | ABSTRACT
Objective
The risk of clinical consequences in prenatal cases with de novo small supernumerary marker chromosomes (sSMC), often in mosaic conditions, is not easy to predict, which results in difficulties in genetic counseling.
Method
In this study, we evaluated the frequency, the chromosomal origin, and the clinical indication of 104 de novo sSMC detected in a monocenter survey on the basis of 143 000 consecutive prenatal diagnoses, and we assessed the reliability of molecular cytogenetics technologies for sSMC characterization.
Results
We detected a de novo sSMC frequency of 0.072%. Its incidence in advanced maternal age group is statistically different from that found in maternal anxiety indication (<35 years old). A higher prevalence of mosaicism in chorionic villi sampling (CVS) than in amniotic fluids was also revealed related to confined placental mosaicisms. The risk of confirmation in amniotic fluids of mosaics previously revealed at CVS was 33.3%. No uniparental disomy conditions were found when imprinted chromosomes were involved in the occurrence of de novo sSMC. The majority of de novo sSMC were acrocentric derived‐chromosomes, and a neocentromere formation was observed in one pregnancy.
Conclusion
Our data support that array comparative genomic hybridization has improved sSMC characterization and demonstrate its utility in supporting genetic counseling. We propose a workflow for de novo sSMC characterization. © 2014 John Wiley & Sons, Ltd.
What's already known about this topic?
Frequency and characterization of de novo small supernumerary marker chromosomes detected in prenatal diagnosis on chorionic villi sampling and amniotic fluids.
Predominance of markers derived from 15 samples and the association with maternal age.
What does this study add?
The rate of confirmation at amniocentesis of mosaic markers found in chorionic villi sampling considering the different combinations of the affected placental tissues and the lack of any uniparental disomy found for markers of imprinted chromosomes.
Workflow for de novo marker characterization in prenatal diagnosis based on our experience of 143 000 consecutive cases. |
---|---|
Bibliography: | istex:B0856FAEFC13743CBFED91ACA0E138972EA30983 ArticleID:PD4330 ark:/67375/WNG-GPX9MZV1-W are full‐time employees of TOMA Advanced Biomedical Assays S.p.A. and declare no conflict of interest. Federico Maggi is the President, Founder, and CEO of TOMA laboratory. Giuseppe Simoni is the Scientific Director of TOMA laboratory. Federico Maggi and Giuseppe Simoni are the holders of TOMA Advanced Biomedical Assays S.p.A. Founding sources: None Conflicts of interest: Francesca Malvestiti, Simona De Toffol, Beatrice Grimi, Sara Chinetti, Livia Marcato, Cristina Agrati, Anna Maria Di Meco, Giuditta Frascoli, Anna Trotta, Barbara Malvestiti, Anna Ruggeri, Francesca Dulcetti, and Francesca Romana Grati ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0197-3851 1097-0223 |
DOI: | 10.1002/pd.4330 |